ArticlePharmaceutics2022

Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.